{ "cik": 1326110, "cik_padded": "0001326110", "entityName": "ImmunityBio, Inc.", "fiscal_years": [ { "accn": "0001326110-26-000030", "filed": "2026-02-23", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3846000.0, "cash": 88334000.0, "eps_diluted": -0.38, "free_cash_flow": -308782000.0, "net_income": -351398000.0, "operating_cash_flow": -304936000.0, "operating_income": -256027000.0, "revenue": 113288000.0, "stockholders_equity": -500469000.0, "total_assets": 501898000.0, "total_liabilities": 1001472000.0 }, "period_end": "2025-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 6.683146829433706, "roa_avg2y": -0.7942714484460874, "roa_period_end": -0.7001382751076912, "roe_avg2y": 0.7102055747614866 } }, { "accn": "0001326110-26-000030", "filed": "2026-02-23", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6888000.0, "cash": 143428000.0, "eps_diluted": -0.62, "free_cash_flow": -398124000.0, "net_income": -413564000.0, "operating_cash_flow": -391236000.0, "operating_income": -344182000.0, "revenue": 14745000.0, "stockholders_equity": -489098000.0, "total_assets": 382933000.0, "total_liabilities": 871062000.0 }, "period_end": "2024-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 22.705787781350484, "roa_avg2y": -0.932095989902917, "roa_period_end": -1.079990494420695, "roe_avg2y": 0.7686455995576558 } }, { "accn": "0001326110-26-000030", "filed": "2026-02-23", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 30584000.0, "cash": 265453000.0, "eps_diluted": -1.15, "free_cash_flow": -397341000.0, "net_income": -583196000.0, "operating_cash_flow": -366757000.0, "operating_income": -362250000.0, "revenue": 622000.0, "stockholders_equity": -586987000.0, "total_assets": 504452000.0, "total_liabilities": 1090389000.0 }, "period_end": "2023-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 1.5916666666666666, "roa_avg2y": -1.3456174839180073, "roa_period_end": -1.1560981024953811, "roe_avg2y": 1.1276962315119006 } }, { "accn": "0001326110-25-000033", "filed": "2025-03-03", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 78162000.0, "cash": 104641000.0, "eps_diluted": -1.04, "free_cash_flow": -415671000.0, "net_income": -416567000.0, "operating_cash_flow": -337509000.0, "operating_income": -351298000.0, "revenue": 240000.0, "stockholders_equity": -447327000.0, "total_assets": 362356000.0, "total_liabilities": 812176000.0 }, "period_end": "2022-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.7430406852248393, "roa_avg2y": -1.002247174791222, "roa_period_end": -1.1496070163044079, "roe_avg2y": 1.2083161711385062 } }, { "accn": "0001326110-24-000037", "filed": "2024-03-19", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 33563000.0, "cash": 181101000.0, "eps_diluted": -0.89, "free_cash_flow": -307982000.0, "net_income": -346790000.0, "operating_cash_flow": -274419000.0, "operating_income": -330280000.0, "revenue": 934000.0, "stockholders_equity": -242173000.0, "total_assets": 468910000.0, "total_liabilities": 712823000.0 }, "period_end": "2021-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 0.543801652892562, "roa_avg2y": -1.004764657224272, "roa_period_end": -0.739566228060822, "roe_avg2y": 1.9160674179031496 } }, { "accn": "0001326110-23-000018", "filed": "2023-03-01", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1669000.0, "cash": 34915000.0, "eps_diluted": -0.59, "free_cash_flow": -173393000.0, "net_income": -221851000.0, "operating_cash_flow": -171724000.0, "operating_income": -220880000.0, "revenue": 605000.0, "stockholders_equity": -119808000.0, "total_assets": 221381000.0, "total_liabilities": 339871000.0 }, "period_end": "2020-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.7252497729336966, "roa_avg2y": -1.2172760792748503, "roa_period_end": -1.0021230367556384, "roe_avg2y": -509.4167623421355 } }, { "accn": "0001326110-22-000011", "filed": "2022-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4287000.0, "cash": 75801000.0, "eps_diluted": -0.43, "free_cash_flow": -156396000.0, "net_income": -157777000.0, "operating_cash_flow": -152109000.0, "operating_income": -156251000.0, "revenue": 2202000.0, "stockholders_equity": 120679000.0, "total_assets": 143123000.0, "total_liabilities": 22444000.0 }, "period_end": "2019-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 45.851063829787236, "roa_avg2y": -0.970717346565233, "roa_period_end": -1.1023874569426297, "roe_avg2y": -1.1832461518270618 } }, { "accn": "0001564590-21-010945", "filed": "2021-03-04", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13102000.0, "cash": 16821000.0, "free_cash_flow": -76483000.0, "net_income": -96226000.0, "operating_cash_flow": -63381000.0, "operating_income": -98389000.0, "revenue": 47000.0, "stockholders_equity": 146006000.0, "total_assets": 181950000.0, "total_liabilities": 35944000.0 }, "period_end": "2018-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 0.044444444444444446, "roa_avg2y": -0.4450889243507019, "roa_period_end": -0.5288595768068151, "roe_avg2y": -0.5274825270659175 } }, { "accn": "0001564590-21-010945", "filed": "2021-03-04", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 34815000.0, "cash": 23872000.0, "free_cash_flow": -83595000.0, "net_income": -96423000.0, "operating_cash_flow": -48780000.0, "operating_income": -99120000.0, "revenue": 45000.0, "stockholders_equity": 218844000.0, "total_assets": 250440000.0, "total_liabilities": 31596000.0 }, "period_end": "2017-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 0.022727272727272728, "roa_avg2y": -0.3395558654496281, "roa_period_end": -0.3850143747005271, "roe_avg2y": -0.37645970226173325 } }, { "accn": "0001564590-20-012816", "filed": "2020-03-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6560000.0, "cash": 8083000.0, "free_cash_flow": -45153000.0, "net_income": -120809000.0, "operating_cash_flow": -38593000.0, "operating_income": -124500000.0, "revenue": 44000.0, "stockholders_equity": 293418000.0, "total_assets": 317496000.0, "total_liabilities": 24078000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.3805055811726762 } } ], "latest_filing": { "accn": "0001326110-26-000030", "filed": "2026-02-23", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001326110.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001326110.json" }, "ticker": "IBRX" }